Tetracycline activity enhancement using doxycycline or sancyclin

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514152, A61K 3165

Patent

active

052583724

ABSTRACT:
Methods and products for overcoming bacterial resistance to tetracycline-type antibiotics by inhibiting the plasmid-mediated active efflux system for tetracycline in the resistant bacterial cell by administering with tetracycline efflux system blocking agents of doxycycline or sancycline, thereby increasing the sensitivity of the resistant cell to tetracycline type antibiotics.

REFERENCES:
patent: 3454697 (1969-07-01), Joyner et al.
patent: 4024272 (1977-05-01), Rogalaski et al.
patent: 4126680 (1978-11-01), Armstrong
patent: 4806529 (1989-02-01), Levy
Grassi et al., New Trends in Antibodies: Research and Therapy, pp. 3-54 (1981).
CA: 89: 71494n (Connamacher et al.) (1978).
CA: 90: 198211u (Samra et al.) (1979).
CA: 83: 1393f (Candanoza et al.) (1975).
CA: 81: 115200e (Leigh et al.) (1974).
CA: 82: 26560a (Lebek et al.) (1975).
CA: 74: 74941g (Kuck et al.) (1971).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Tetracycline activity enhancement using doxycycline or sancyclin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tetracycline activity enhancement using doxycycline or sancyclin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetracycline activity enhancement using doxycycline or sancyclin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1757556

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.